Variation in the response of T cells to Concanavalin A after in vitro exposure to benzo[a]pyrene and 2-aminofluorene

Immunopharmacology and Immunotoxicology

Volumn 18, Issue 2, 1996, Pages 309-321

  Lee, Mark ^a,b   Kirlin, Ward ^a   Sturrup, Melanie ^a   Rodriguez, Jose ^a   Urso, Paul ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b CLARK ATLANTA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 FLUORENYLAMINE; 3 HYDROXYBENZO[A]PYRENE; BENZO[A]PYRENE; CONCANAVALIN A; N (2 FLUORENYL)ACETAMIDE; N HYDROXY 2 FLUORENYLAMINE; POLYCYCLIC AROMATIC HYDROCARBON;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; DRUG EFFECT; DRUG SCREENING; FEMALE; IMMUNOPHARMACOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

ANIMALIA;

EID: 0029941060     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923979609052738     Document Type: Article

References (31)

1. Blanton, R., Lyte, M., Myers, M., and Bick, P. Immunomodulation by polyaromatic hydrocarbons in mice and murine cells. Cancer Res., 46:2735, 1985.
2. Ginsberg, G., Atherholt, T., and Butler, G. Benzo[a]pyrene-induced immunotoxicity: Comparison to DNA adduct formation in vivo, in cultured splenocytes, and in microsomal systems. J. Tox. Envir. Health, 28:205, 1989.
3. Hakim, A. Peripheral blood lymphocytes from patients with cancer lack interleukin-2 receptor expression: Isolation of mRNA encoding IL-2R. Can. Det. Prev., 12:59, 1988.
4. Kawabata, T. and White, K. Suppression of the in vitro humoral immune response of mouse splenocytes by benzo(a)pyrene metabolites and inhibition of benzo(a)pyrene-induced immunosuppression by α-naphthoflavone. Cancer Res., 47:2317, 1987.
5. Lioy, P. Human exposure to benzo[a]pyrene: Some more of the story; a letter to the editor. Toxicol. and Ind. Health, 8:213, 1992.
6. Lyte, M., Blanton, R., Myers, M., and Bick, P. Effect of in vivo administration of the carcinogen benzo[a]pyrene on interleukin-2 and interleukin-3 production. Int. J. Immunopharmac., 9:307, 1987.
7. Pallardy, M., House, R., and Dean, J. Molecular Mechanism of 7,12-Dimethylbenz[a]anthracene-induced immunosuppression: Evidence for action via the interleukin 2 pathway. Mol. Pharmacol., 36:128, 1988.
8. Urso, P., Gengozian, N., Rossi, R., and Johnson, R. Suppression of humoral and cell-mediated immune responses in vitro by benzo[a]pyrene. J. Immunopharm. 8:223, 1986.
9. Urso, P. and Gengozian, N. Alterations in the humoral immune response and tumor frequencies in mice exposed to benzo[a]pyrene and X-rays before or after Birth. J. Toxicol. Environ. Health, 10:817, 1982.
10. Urso, P. and Gengozian, N. Subnormal expression of cell-mediated and humoral immune responses in progeny disposed toward a high incidence of tumors after in utero exposure to benzo[a]pyrene. J. Toxicol. Environ. Health, 14:569, 1984.
11. Kim, B., Kim, D., Holsapple, M., and Yang, K. Immunosuppressive effects of 2-acetylaminofluorene and 2-aminofluorene on murine splenocytes culture. Drug and Chem. Toxicol., 12:297, 1989.
12. Frederick, C., Mays, J., Ziegler, D., Guengerich, F., and Kadlubar, F. Cytochrome P-450 and flavin-containing monooxygenase-catalyzed formation of the carcinogenic N-OH-AF and its covalent binding to nuclear DNA. Cancer Res., 42:2671, 1982.
13. Gelboin, H. Benzo[a]pyrene metabolism, activation, and carcinogenesis: Role and regulation of mixed-function oxidases and related enzymes. Physiological Reviews, 60:1107, 1980.
14. Guengerich, F. Roles of Cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res., 48:2946, 1988.
15. Kuntzman, R., Mark, L., Brand, M., Jacobson, M., Levin, M., and Conney, A. Metabolism of drugs and carcinogens by human liver enzymes. J. Pharmacol. Exp. Ther., 152:152, 1966.
16. Smith, B., Springfield, J., and Gutmann, H. Interaction of the synthetic ultimate carcinogens, N-sulfonoxy- and N-acetoxy-2-acetylaminoflourene, and of enzymatically activated N-hydroxy-2-acetylaminofluorene with nucleophiles. Carcinogenesis, 7:405, 1986.
17. Weston, A., Rowe, M., Manchester, D., Farmer, P., Mann, D., and Harris, C. Fluorescence and mass spectral evidence for the formation of benzo[a]pyrene anti-diol-epoxide-DNA and -hemoglobin adducts in humans. Carcinogenesis, 10:251, 1989.
18. Heidelberger, C. Gehly, E., Fahl, W., and Jefcoate, C. Microsomes, Drug Oxidations and Chemical Carcinogenesis (Coan, M, Cooney, A., Estabrook, R., Gelboin, H., and O'Brien, P. Eds.), p. 1023, Academic Press, New York, 1980.
19. Chilson, O. and Kelly-Chilson, A. Mitogenic lectins bind to the antigen receptor on human lymphocytes. Eur. J. Immunol., 19:389, 1989.
20. Urso, P., Zhang, W., Cobb, J. Immunological consequences from exposure to benzo[a]pyrene during pregnancy. Scand. J. Immunol., 36:203, 1992.
21. Wojdani, A. and Lawrence, A. Alterations in cell-mediated immune functions induced in mouse splenic lymphocytes by polycyclic aromatic hydrocarbons. Cancer Res., 44:942, 1984.
22. Weiss, A. and Imboden, J. Cell surface molecules and early events involved in human T lymphocyte activation. Adv. Immun., 41:1, 1987.
23. Shen, J., Wegenke, M., and Wolff, T. Capability of human blood cells to form the DNA adduct, C8-(N2-aminofluorenyl)-deoxyguanosine-3′-5′-diphosphate from 2-aminofluorene. Carcinogenesis, 11:1441, 1990.
24. Borgen, A., Davey, H., Castagnoli, N., Crocker, T., Rasmussen, R., and Wang, I. Metabolic conversion of benzo(a)pyrene by syrian hamster liver microsomes and binding of metabolites to deoxyribonucleic acid. J. Med. Chem., 16:502, 1973.
25. Dean, J., Luster, M., Boorman, G., and Lauer, L. Procedures available to examine the immunotoxicity of chemicals and drugs. Pharmacol. Rev., 34:137, 1982.
26. Blanton, R., Myers, M., and Bick, P. Modulation of immunocompetent cell populations by benzo[a]pyrene. Toxicol. Appl. Pharmacol, 13:267, 1988.
27. Ladies, G., Kawabata, T., and White K. Suppression of the in vitro humoral immune response of mouse splenocytes by 7,12-dimethylbenz[a]anthracene metabolites and inhibition of immunosuppression by alpha-naphthaflavone. Toxicol. Appl. Pharmacol. 110:31, 1991.
28. Zhang, W., Cobb, J., Rodriguez, J., Kirlin, W., Lee, M. and Urso, P. Benzo[a]pyrene affects functional profile of developing T-cells. 8TH INTERNATIONAL CONGRESS OF IMMUNOLOGY, 1992.
29. Mattano, S. and Weber, W. Kinetics of arylamine N-acetyltransferase in tissues from rapid and slow acetylator mice. Carcinogenesis, 8:133, 1987.
30. s slow acetylator congenic mice. Drug Metab. Dispos. Biol. Fate Chem., 21:1057, 1993.
31. Levy, G., Chung, J., and Weber, W. 2-Aminofluorene metabolism and DNA adduct formation by mononuclear leukocytes from rapid and slow acetylator mouse strains. Carcinogenesis, 15:353, 1994.